ANCHOR CRC: Results from a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer Meeting Abstract
| Authors: | Van Cutsem, E.; Taieb, J.; Yaeger, R.; Yoshino, T.; Maiello, E.; Elez, E.; Dekervel, J.; Ross, P.; Ruiz Casado, A.; Graham, J.; Kato, T.; Ruffinelli, J.; André, T.; Carriere Roussel, E.; Klauck, I.; Groc, M.; Grothey, A.; Vedovato, J.; Tabernero, J. |
| Abstract Title: | ANCHOR CRC: Results from a single-arm, phase 2 study of encorafenib, binimetinib plus cetuximab in previously untreated BRAF V600E-mutant metastatic colorectal cancer |
| Meeting Title: | ESMO 23rd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2021 Jun 30-Jul 3 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-07-01 |
| Start Page: | S222 |
| Language: | English |
| ACCESSION: | WOS:000670004200340 |
| DOI: | 10.1016/j.annonc.2021.05.014 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O-10 -- Source: Wos |
